Total Payments
$1,848
2024 Payments
$653.73
Companies
26
Transactions
92
Medicare Patients
2,821
Medicare Billing
$177,959
Payment Breakdown by Category
Food & Beverage$1,848 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,848 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $327.93 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $234.92 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $232.04 | 9 | $0 (2024) |
| Novo Nordisk Inc | $175.54 | 9 | $0 (2024) |
| Lilly USA, LLC | $120.32 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $103.21 | 6 | $0 (2024) |
| Boston Scientific Corporation | $79.26 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $77.22 | 4 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $52.91 | 3 | $0 (2024) |
| PFIZER INC. | $45.61 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $653.73 | 31 | AstraZeneca Pharmaceuticals LP ($135.38) |
| 2023 | $485.05 | 27 | Lilly USA, LLC ($83.05) |
| 2022 | $451.61 | 22 | ABBVIE INC. ($87.01) |
| 2021 | $257.50 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($86.79) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Biological | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
| 07/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: UROLOGY | ||||||
| 07/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Endocrinology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: VACCINE | ||||||
| 06/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: VIROLOGY | ||||||
| 05/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Inflammation | ||||||
| 04/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Diabetes | ||||||
| 03/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 649 | 1,088 | $215,495 | $45,787 |
| 2022 | 19 | 794 | 1,176 | $232,954 | $50,808 |
| 2021 | 17 | 798 | 1,151 | $198,087 | $44,660 |
| 2020 | 12 | 580 | 1,013 | $180,584 | $36,704 |
Total Patients
2,821
Total Services
4,428
Medicare Billing
$177,959
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 430 | $130,720 | $23,965 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 146 | $30,076 | $7,052 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $22,554 | $6,737 | 29.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 72 | $13,896 | $3,259 | 23.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 37 | 43 | $4,515 | $1,744 | 38.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 23 | 26 | $3,250 | $1,128 | 34.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 83 | 157 | $1,256 | $503.97 | 40.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 44 | $1,452 | $418.88 | 28.8% |
| 92250 | Photography of the retina | Office | 2023 | 15 | 15 | $3,480 | $355.59 | 10.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 30 | $2,010 | $254.00 | 12.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 27 | $1,971 | $249.87 | 12.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 35 | $315.00 | $119.35 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 438 | $133,152 | $24,351 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 196 | $40,376 | $8,896 | 22.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 72 | 72 | $25,517 | $8,201 | 32.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 40 | $2,920 | $1,216 | 41.7% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 29 | 30 | $3,160 | $1,216 | 38.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 27 | 29 | $3,045 | $1,183 | 38.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 24 | 25 | $3,200 | $1,037 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,592 | $979.46 | 17.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 25 | 29 | $3,625 | $693.20 | 19.1% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 17 | 17 | $2,040 | $681.87 | 33.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,500 | $376.36 | 25.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 15 | 15 | $735.00 | $316.35 | 43.0% |
| 92228 | Imaging of retina with remote review by physician | Office | 2022 | 14 | 14 | $1,428 | $302.76 | 21.2% |
About Christopher Haas, NP
Christopher Haas, NP is a Family healthcare provider based in Gettysburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1902282536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Haas, NP has received a total of $1,848 in payments from pharmaceutical and medical device companies, with $653.73 received in 2024. These payments were reported across 92 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,848).
As a Medicare-enrolled provider, Haas has provided services to 2,821 Medicare beneficiaries, totaling 4,428 services with total Medicare billing of $177,959. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Gettysburg, PA
- Active Since 08/05/2015
- Last Updated 01/13/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1902282536
Products in Payments
- JARDIANCE (Drug) $263.55
- VRAYLAR (Drug) $143.13
- FARXIGA (Drug) $139.67
- Ozempic (Drug) $124.29
- UBRELVY (Drug) $88.38
- General - Pain Management (Device) $79.26
- TRELEGY ELLIPTA (Drug) $77.22
- BAQSIMI (Drug) $72.50
- BREZTRI (Drug) $67.11
- GEMTESA (Drug) $52.91
- BELSOMRA (Drug) $47.38
- OneTouch Verio Reflect (Device) $40.38
- GARDASIL (Biological) $39.97
- QULIPTA (Drug) $39.09
- MAVYRET (Drug) $38.36
- Otezla (Drug) $34.94
- Rybelsus (Drug) $33.67
- NURTEC ODT (Drug) $33.32
- FreeStyle Libre 2 (Device) $29.45
- INVEGA SUSTENNA (Drug) $28.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Gettysburg
Mrs. Lynn Wingert, Crnp, CRNP
Family — Payments: $5,746
Family $5,746
Nikki Bailes, Crnp, CRNP
Family — Payments: $1,792
Family $1,792
Angela Borger, Crnp, CRNP
Family — Payments: $1,693
Family $1,693
Judith Williams
Family — Payments: $1,497
Family $1,497
Stacey Spahr, Crnp, CRNP
Family — Payments: $961.73
Family $961.73
Erika Reindollar, Crnp, CRNP
Family — Payments: $545.60
Family $545.60